Northwestern University
· Drug works differently than any other bladder cancer treatment
· Bladder cancer survival is poor
· Drug is being tested in clinical trials for late-stage bladder cancer led by physicians and scientists from Northwestern
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
